Literature DB >> 30923253

Comparing two posterior quadratus lumborum block approaches with low thoracic erector spinae plane block: an anatomic study.

Hesham Elsharkawy1, Gausan Ratna Bajracharya2, Kariem El-Boghdadly3, Richard L Drake4, Edward R Mariano5,6.   

Abstract

BACKGROUND AND OBJECTIVES: Both posterior quadratus lumborum (QL) and erector spinae plane (ESP) blocks have been described as new truncal interfascial plane blocks. Distribution of injectate is influenced by fascial anatomy; therefore, different injection sites may produce similar spread. This anatomic study was designed to test the hypothesis that a posteromedial QL block at L2 level will more closely resemble a low thoracic ESP block when compared with the posterolateral approach at L2 level.
METHODS: Left-sided ESP blocks were performed in six cadavers at T10-11. Three of these cadavers received right-sided posteromedial QL block at L2, while the other three received right-sided posterolateral QL block at L2. All injections were composed of 20 mL methylcellulose 0.5 % mixed with India ink and 10 mL of Omnipaque (Iohexol) 240 mg/mL. CT 24 hours after injection and cadaver dissection were used to evaluate injectate spread.
RESULTS: Cephalocaudal spread of injectate by CT and cadaveric dissection was highly correlated (r=0.85 [95% CI 0.51 to 0.95]). Cadaver dissection showed ESP injectate spread deep to the muscle (mean [SD]) 11.7 (2.3) levels compared with 7.3 (1.2) levels for posterolateral QL and 9.7 (1.5) for posteromedial QL (p=0.04 overall, with a statistically significant pairwise difference between ESP and posterolateral QL only). The subcostal nerve and dorsal rami were commonly involved in most blocks, but the paravertebral space and ventral rami had inconsistent involvement. The lumbocostal ligament limited cranial spread from the posterlateral QL block approach.
CONCLUSIONS: The posteromedial QL block at L2 produces more cranial spread beyond the lumbocostal ligament than the posterolateral QL block, and this spread is comparable with a low thoracic ESP block. Both posterior QL and ESP blocks show unreliable spread of injectate to the paravertebral space and ventral rami, but the dorsal rami were frequently covered. © American Society of Regional Anesthesia & Pain Medicine 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anatomy; cadaver; erector spinae plane block; interfascial plane blocks; quadratus lumborum block; regional anesthesia

Year:  2019        PMID: 30923253     DOI: 10.1136/rapm-2018-100147

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  5 in total

1.  Ultrasound-Guided Quadratus Lumborum Block Enhances the Quality of Recovery after Gastrointestinal Surgery: A Randomized Controlled Trial.

Authors:  Qing-Ren Liu; Yu-Chen Dai; Jue Xie; Xiang Li; Xing-Bing Sun; Jie Sun
Journal:  Pain Res Manag       Date:  2022-04-30       Impact factor: 2.667

Review 2.  Mechanisms of action of the erector spinae plane (ESP) block: a narrative review.

Authors:  Ki Jinn Chin; Kariem El-Boghdadly
Journal:  Can J Anaesth       Date:  2021-01-06       Impact factor: 6.713

3.  Distribution of the T12 erector spinal muscle plane block in the dorsal region guided by ultrasound.

Authors:  Jin-Feng Zhang; Wei-Wei Zhang; Jia Wang; Hao Guo; Ting Wang
Journal:  J Orthop Surg Res       Date:  2021-01-12       Impact factor: 2.359

4.  Analgesic effects of erector spinae plane block for patients after breast surgery: a systematic review and meta-analysis.

Authors:  Hui-Fang Li; Qi-Hong Shen; Xu-Yan Zhou; Xu Shen
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Dexmedetomidine combined with ropivacaine for erector spinae plane block after posterior lumbar spine surgery: a randomized controlled trial.

Authors:  Wang Yi-Han; Tang Rong; Li Jun; Wang Min; Zhang Yan; Li Yi; Liu Jie-Ting; Huang Sheng-Hui
Journal:  BMC Musculoskelet Disord       Date:  2022-03-11       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.